FRANKLIN LAKES, N.J.,
Aug. 13, 2020 /PRNewswire/ -- BD
(Becton, Dickinson and Company) (NYSE:BDX), a leading global
medical technology company, announced today that it will present at
the UBS Genomics 2.0 and MedTech Innovations Virtual Summit on
Thursday, August 13, 2020, at
3:30 p.m. ET.
A live webcast of BD's presentation can be accessed from the BD
corporate website at www.bd.com/investors and will be available for
replay through Thursday, August 20,
2020.
About BD
BD is one of the largest global medical technology companies in the
world and is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. The company
supports the heroes on the frontlines of health care by developing
innovative technology, services and solutions that help advance
both clinical therapy for patients and clinical process for health
care providers. BD and its 65,000 employees have a passion and
commitment to help enhance the safety and efficiency of clinicians'
care delivery process, enable laboratory scientists to accurately
detect disease and advance researchers' capabilities to develop the
next generation of diagnostics and therapeutics. BD has a presence
in virtually every country and partners with organizations around
the world to address some of the most challenging global health
issues. By working in close collaboration with customers, BD can
help enhance outcomes, lower costs, increase efficiencies, improve
safety and expand access to health care. For more information on
BD, please visit bd.com.
Contact:
Kristen Cardillo, Communications –
201-847-5657
Monique N. Dolecki, Investor
Relations – 201-847-5378
View original
content:http://www.prnewswire.com/news-releases/bd-to-present-at-ubs-genomics-2-0-and-medtech-innovations-virtual-summit-301111859.html
SOURCE BD (Becton, Dickinson and Company)